These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 22691538)

  • 1. Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 protein.
    Guo HC; Feng XM; Sun SQ; Wei YQ; Sun DH; Liu XT; Liu ZX; Luo JX; Yin H
    Virol J; 2012 Jun; 9():108. PubMed ID: 22691538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of robust immunity response in mice by dual-expression-system-based recombinant baculovirus expressing the capsid protein of porcine circovirus type 2.
    Ye Y; Cheng X; Zhang J; Tong T; Lin W; Liao M; Fan H
    Virol J; 2013 Oct; 10():316. PubMed ID: 24161107
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of porcine circovirus type 2 capsid protein targeting to different subcellular compartments.
    Fan H; Xiao S; Tong T; Wang S; Xie L; Jiang Y; Chen H; Fang L
    Mol Immunol; 2008 Feb; 45(3):653-60. PubMed ID: 17709139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the immunogenicity of a porcine circovirus type 2 DNA vaccine by a recombinant plasmid coexpressing capsid protein and porcine interleukin-6 in mice.
    Guo XQ; Wang LQ; Qiao H; Yang XW; Yang MF; Chen HY
    Microbiol Immunol; 2015 Mar; 59(3):174-80. PubMed ID: 25664504
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenicity of a recombinant pseudorabies virus expressing ORF1-ORF2 fusion protein of porcine circovirus type 2.
    Ju C; Fan H; Tan Y; Liu Z; Xi X; Cao S; Wu B; Chen H
    Vet Microbiol; 2005 Aug; 109(3-4):179-90. PubMed ID: 16006077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Construction and immunogenicity of a recombinant pseudorabies virus co-expressing porcine circovirus type 2 capsid protein and interleukin 18.
    Zheng LL; Guo XQ; Zhu QL; Chao AJ; Fu PF; Wei ZY; Wang SJ; Chen HY; Cui BA
    Virus Res; 2015 Apr; 201():8-15. PubMed ID: 25701744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlates of Protection Following Vaccination with Inactivated Porcine Circovirus 2 Vaccines.
    Zanotti C; Martinelli N; Lelli D; Amadori M
    Viral Immunol; 2015 Dec; 28(10):600-8. PubMed ID: 26401584
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of swine against post-weaning multisystemic wasting syndrome (PMWS) by porcine circovirus type 2 (PCV2) proteins.
    Blanchard P; Mahé D; Cariolet R; Keranflec'h A; Baudouard MA; Cordioli P; Albina E; Jestin A
    Vaccine; 2003 Nov; 21(31):4565-75. PubMed ID: 14575769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporation of ORF2 from Porcine Circovirus Type 2(PCV2) into genetically encoded nanoparticles as a novel vaccine using a self-aggregating peptide.
    Zepeda-Cervantes J; Cruz-Reséndiz A; Sampieri A; Carreón-Nápoles R; Sánchez-Betancourt JI; Vaca L
    Vaccine; 2019 Mar; 37(14):1928-1937. PubMed ID: 30824359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative effects of vaccination against porcine circovirus type 2 (PCV2) and porcine reproductive and respiratory syndrome virus (PRRSV) in a PCV2-PRRSV challenge model.
    Park C; Oh Y; Seo HW; Han K; Chae C
    Clin Vaccine Immunol; 2013 Mar; 20(3):369-76. PubMed ID: 23302743
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immune responses of mice immunized by DNA plasmids encoding PCV2 ORF 2 gene, porcine IL-15 or the both.
    Dong B; Feng J; Lin H; Li L; Su D; Tu D; Zhu W; Yang Q; Ren X
    Vaccine; 2013 Nov; 31(48):5736-44. PubMed ID: 24091312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hollow mesoporous silica nanoparticles as delivery vehicle of foot-and-mouth disease virus-like particles induce persistent immune responses in guinea pigs.
    Bai M; Dong H; Su X; Jin Y; Sun S; Zhang Y; Yang Y; Guo H
    J Med Virol; 2019 Jun; 91(6):941-948. PubMed ID: 30701562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction and immunogenicity of recombinant adenovirus expressing the capsid protein of porcine circovirus 2 (PCV2) in mice.
    Wang X; Jiang W; Jiang P; Li Y; Feng Z; Xu J
    Vaccine; 2006 Apr; 24(16):3374-80. PubMed ID: 16524646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Th1-biased immune efficacy of porcine circovirus type 2 Cap-protein-based subunit vaccine when coadministered with recombinant porcine IL-2 or GM-CSF in mice.
    Wang Y; Lu Y; Liu D; Wei Y; Guo L; Wu H; Huang L; Liu J; Liu C
    Appl Microbiol Biotechnol; 2015 Feb; 99(3):1155-63. PubMed ID: 25487886
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation and immunogenicity of a recombinant pseudorabies virus expressing cap protein of porcine circovirus type 2.
    Song Y; Jin M; Zhang S; Xu X; Xiao S; Cao S; Chen H
    Vet Microbiol; 2007 Jan; 119(2-4):97-104. PubMed ID: 17005335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective immunity conferred by porcine circovirus 2 ORF2-based DNA vaccine in mice.
    Sylla S; Cong YL; Sun YX; Yang GL; Ding XM; Yang ZQ; Zhou YL; Yang M; Wang CF; Ding Z
    Microbiol Immunol; 2014 Jul; 58(7):398-408. PubMed ID: 24845706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Construction and immunogenicity of recombinant adenovirus expressing ORF2 of PCV2 and porcine IFN gamma.
    Genmei L; Manlin L; Ruiai C; Hongliang H; Dangshuai P
    Vaccine; 2011 Nov; 29(47):8677-82. PubMed ID: 21945259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Immune efficacy in mice by recombinant pseudorabies virus PGO expressing ORF2 gene of porcine circovirus type 2].
    Chao A; Fu P; Guo X; Gao X; Cui B; Chen H
    Wei Sheng Wu Xue Bao; 2014 Feb; 54(2):211-7. PubMed ID: 24818470
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Replacing the decoy epitope of PCV2 capsid protein with epitopes of GP3 and/or GP5 of PRRSV enhances the immunogenicity of bivalent vaccines in mice.
    Jung BK; Kim HR; Jang H; Chang KS
    J Virol Methods; 2020 Oct; 284():113928. PubMed ID: 32650038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interference of porcine circovirus type 2 ORF2 immunogenicity by ORF1 and ORF3 mixed DNA immunizations in mice.
    Shen HG; Zhou JY; Zhang X; Huang ZY; He JL; Yan Y
    Virology; 2009 Oct; 393(1):104-11. PubMed ID: 19709712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.